- Mar 22, 2012
Disappointing. Generally safe but no indication of efficacy
Safety and Effectiveness of Long-term Intravenous Edaravone Therapy for Amyotrophic Lateral Sclerosis
This multicenter cohort study uses real-world clinical data to compare the long-term safety and effectiveness of intravenous edaravone plus riluzole therapy vs propensity score–matched controls receiving riluzole therapy alone among patients with amyotrophic lateral sclerosis.